Evidence map›Paper›PMID 33098673›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2021

Utilization cost of maternity services for childbirth among pregnant women with coronavirus disease 2019 in Nigeria's epicenter.

Aduragbemi Banke-Thomas, Christian Chigozie Makwe, Mobolanle Balogun, Bosede Bukola Afolabi, Theresa Amaogechukwu Alex-Nwangwu, Charles Anawo Ameh

Open access · bronzeAbstract read
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Aduragbemi Banke-ThomasLSE Health, London School of Economics and Political Science, London, UK.
Christian Chigozie MakweDepartment of Obstetrics and Gynecology, College of Medicine of the University of Lagos, Lagos, Nigeria.
Mobolanle BalogunDepartment of Community Health and Primary Care, College of Medicine of the University of Lagos, Lagos, Nigeria.
Bosede Bukola AfolabiDepartment of Obstetrics and Gynecology, College of Medicine of the University of Lagos, Lagos, Nigeria.
Theresa Amaogechukwu Alex-NwangwuPharmacy Department (Inpatient and Drug Production Services, Lagos University Teaching Hospital, Lagos, Nigeria.
Charles Anawo AmehCentre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK.
University of Lagos · NGLagos University Teaching Hospital · NGLiverpool School of Tropical Medicine · GBLondon School of Economics and Political Science · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate utilization costs of spontaneous vaginal delivery (SVD) and cesarean delivery (CD) for pregnant women with coronavirus disease 2019 (COVID-19) at the largest teaching hospital in Lagos, the pandemic's epicenter in Nigeria.

methodsWe collected facility-based and household costs of all nine pregnant women with COVID-19 managed at the hospital. We compared their mean facility-based costs with those paid by pregnant women pre-COVID-19, identifying cost-drivers. We also estimated what would have been paid without subsidies, testing assumptions with a sensitivity analysis.

resultsTotal utilization costs ranged from US $494 for SVD with mild COVID-19 to US $4553 for emergency CD with severe COVID-19. Though 32%-66% of facility-based cost were subsidized, costs of SVD and CD during the pandemic have doubled and tripled, respectively, compared with those paid pre-COVID-19. Of the facility-based costs, cost of personal protective equipment was the major cost-driver (50%). Oxygen was the major driver for women with severe COVID-19 (48%). Excluding treatment costs for COVID-19, mean facility-based costs were US $228 (SVD) and US $948 (CD).

conclusionDespite cost exemptions and donations, utilization costs remain prohibitive. Regulation of personal protective equipment and medical oxygen supply chains and expansion of advocacy for health insurance enrollments are needed in order to minimize catastrophic health expenditure.

Indexed as

AdultCesarean SectionCOVID-19Delivery, ObstetricFemaleHospitals, TeachingHumansMaternal Health ServicesNigeriaParturitionPregnancyPregnancy Complications, InfectiousYoung AdultCoronavirus disease 2019costeconomic evaluationmaternal healthNigeriaout-of-pocket expenditureskilled birth attendance

Identifiers

PMID33098673
PMCPMC9087483
OpenAlexW3094509117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.